NL-OMON46208撤回不适用
' Biomarkers for minimal residual disease in neuro-oncology ': MIRDINO study - MIRDINO study
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 17（—）
入选标准
- •- Radiologicaland if possible histological proven diagnosis of any CNS tumor (M0-M4)
- •- Any age group
- •- Written informed consent obtained of the patients and/or their parents or legal guardians
排除标准
- •see inclusion criteria
研究者
相似试验
已完成
不适用
Minimal residual disease (MRD) monitoring in neuroblastoma to improve MRD based risk stratificatiosmall round blue cell tumor10029211neuroblastomaNL-OMON30826Academisch Medisch Centrum60
招募中
不适用
Biomarker Use in Evidence of Neuronal Damage in Response to Anaesthesia and Surgery (The BOUNDARY Study)DeliriumPostoperative Cognitive DysfunctionAnaesthesiology - AnaestheticsNeurological - DementiasSurgery - Other surgeryACTRN12620000101987St Vincent's Hospital118
尚未招募
不适用
Multiple neurophysiologic biomarkers evaluated the pulmonary function of ALS.amyotrophic lateral sclerosis(ALS)JPRN-UMIN000042222ara Medical University20
已完成
不适用
Development of biomarker in neurodegenerative disease and psychiatric disorderseurodegenerative disease Psychiatric disorderJPRN-UMIN000010883Yokohama City University Graduate School of Medicine58
招募中
不适用
Clinical, molecular and functional biomarkers for PROgnosis, pathomechanisms and treatment strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)Coronavirus Disease 19 (COVID-19)U07.1J12J13J14J15J16J17J18COVID-19, virus identifiedViral pneumonia, not elsewhere classifiedPneumonia due to Streptococcus pneumoniaePneumonia due to Haemophilus influenzaeBacterial pneumonia, not elsewhere classifiedPneumonia due to other infectious organisms, not elsewhere classifiedPneumonia in diseases classified elsewherePneumonia, organism unspecifiedDRKS00022871CAPNETZ STIFTUNG, Geschäftsstelle an der Medizinischen Hochschule Hannover400